TYRA
Tyra BiosciencesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-08-06
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
TYRA vs peer average
40/100
TYRA vs. peer average (D vs. C)
Grade spread
A 2 · B 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
MAZE is the first available peer comparator.
Clinical-stage biotech of similar market capitalization; useful for milestone and financing sensitivity, but not a direct FGFR3 or indication peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TYRA
Tyra Biosciences
MAZE
Maze Therapeutics
Grade
D
D
Momentum
38
27
Value
41
46
Sentiment
53
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs MAZE
TYRA / MAZE
Grade Position
Below peers
TYRA vs. peer average (D vs. C)
40/100
Momentum
38
TYRAValue
41
MAZESentiment
53
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TYRA
MAZE is the first peer returned for this comparison set.